Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SLC12A9 is an immunological and prognostic biomarker for glioma.

Gene - 10 Feb 2025

Li Danting, Zheng Peilin, Huang Shoujun

Abstract excerpt

BACKGROUND: Glioma is one of the most common malignant brain tumors. It has a high rate of progression and a poor prognosis, and effective biomarkers still need to be identified. The solute carrier family 12 (SLC12) family has been reported to be involved in various physiological and pathological processes, but their functional roles in glioma remain unclear. METHODS: Using public datasets, we studied the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Brain Neoplasms
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Glioma

Share to Kaplan-Meier Estimate

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 39622394
DOI: 10.1016/j.gene.2024.149136

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SLC12A9 is an immunological and prognostic biomarker for glioma.PMID 39622394Read ↗

SLC39A1 Contribute to Malignant Progression and Have Clinical Prognostic Impact in GliomasSemantic proximity Read ↗

A potassium‐chloride co‐transporter with altered genome architecture functions as a suppressor in gliomaSemantic proximity Read ↗

SLC43A3 Promotes Oncogenesis and Predicts Poor Prognosis in GliomaSemantic proximity Read ↗

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomasSemantic proximity Read ↗

Identification of SLC1A5 as a Novel Candidate Oncogene for Glioma and Its Involvement in the LGG Immune MicroenvironmentSemantic proximity Read ↗

The prognostic significance and immune correlation of SLC10A3 in low-grade gliomas revealed by bioinformatic analysis and multiple immunohistochemistrySemantic proximity Read ↗

IGSF8 is a potential target for the treatment of gliomasSemantic proximity Read ↗

SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysisSemantic proximity Read ↗

[Advances of glioma biomarkers].Semantic proximity Read ↗

Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in GliomaSemantic proximity Read ↗

High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in GliomaSemantic proximity Read ↗

Comprehensive analysis of predictive significance of PRR11 in glioma at multiple-datasets and single-cell sequencing levelsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.